Home Capital Broker's Calls

DBS maintains 'buy' on Econ Healthcare despite 'negative surprise' for 1H22 results

Atiqah Mokhtar
Atiqah Mokhtar11/23/2021 07:00 PM GMT+08  • 2 min read
DBS maintains 'buy' on Econ Healthcare despite 'negative surprise' for 1H22 results
DBS has kept its target price for Econ Healthcare unchanged at 40 cents.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

DBS Group Research has maintained its “buy” rating for Econ Healthcare (Asia) with an unchanged target price of 40 cents despite the company reporting a 30% y-o-y decline in operating profit for 1HFY2022 ended September.

Calling the results a “negative surprise”, analyst Paul Yong, along with the Singapore research team highlight that the company’s operating margins for 1HFY2022 were weaker than expected, primarily driven by a decline in occupancy rates in Econ Healthcare’s Malaysia nursing homes from 75.5% to 53.8%.

See: Broker's Digest: ST Engineering, Frencken, CDL, Econ Healthcare (Asia)

In addition, losses in nursing homes in Pudu and Chongqing as well as rises in staff costs and consumables also contributed to the lower margins.

Nonetheless, DBS points out that Singapore operations remained resilient, with occupancy rates achieving a historical high of 96.4% in 1HFY2022.

The company’s 44-bed facility in Chongqing also commenced operations in May, with an average occupancy of 14 beds in 1HFY2022.

See also: Brokers' Digest: Food Empire, Lendlease Global Commercial REIT, Raffles Medical Group, SembMarine, Choo Chiang Holdings

Looking ahead, DBS anticipates Econ Healthcare to benefit from ageing population trends, with the private home industry forecast to grow at a compound annual growth rate (CAGR) of 13.6% in Singapore, 11.5% in Malaysia and 16.6% China between 2020 and 2024.

In Singapore, the commencement of Econ Healthcare’s build own lease centres in Henderson and Jurong by FY2023 and FY2027 respectively is expected to drive growth. Growth in Malaysia and China will come from the ramp-up of nursing homes in Puchong, Malaysia (138 beds), Chongqing, China (44 beds), Changshou, China (280 beds) and lastly, Chengdu, China (400 beds) by FY2023.

DBS is projecting Econ Healthcare to achieve a net profit CAGR of 13% between FY2021 and FY2024 and 15% over FY2021 to FY2026 as contributions from the Henderson and Jurong centres kick in.

See also: JP Morgan downgrades local banks as NIMs peak, costs rise, growth slows

For more stories about where the money flows, click here for our Capital section

Shares in Econ Healthcare closed up 0.5 cents or 1.64% higher at 31 cents on Nov 23.

Photo: Samuel Isaac Chua/The Edge Singapore

Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.